$41.01
3.39% today
NYSE, Sep 10, 08:45 pm CET

CryoLife Target price 2025 - Analyst rating & recommendation

CryoLife Classifications & Recommendation:

Buy
85%
Hold
15%

CryoLife Price Target

Target Price $41.82
Price $42.45
Deviation
Number of Estimates 9
9 Analysts have issued a price target CryoLife 2026 . The average CryoLife target price is $41.82. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 11 Analysts recommend CryoLife to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CryoLife stock has an average upside potential 2026 of . Most analysts recommend the CryoLife stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 388.54 446.76
9.76% 14.98%
EBITDA Margin 14.25% 19.75%
56.50% 38.61%
Net Margin -3.43% 1.22%
60.24% 135.53%

9 Analysts have issued a sales forecast CryoLife 2025 . The average CryoLife sales estimate is

$447m
Unlock
. This is
10.30% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$461m 13.81%
Unlock
, the lowest is
$426m 5.25%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $389m 9.76%
2025
$447m 14.98%
Unlock
2026
$495m 10.80%
Unlock
2027
$554m 11.91%
Unlock
2028
$612m 10.49%
Unlock
2029
$679m 11.00%
Unlock
2030
$756m 11.22%
Unlock

8 Analysts have issued an CryoLife EBITDA forecast 2025. The average CryoLife EBITDA estimate is

$88.3m
Unlock
. This is
143.06% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$94.2m 159.39%
Unlock
, the lowest is
$82.3m 126.71%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $55.4m 71.77%
2025
$88.3m 59.42%
Unlock
2026
$104m 17.81%
Unlock
2027
$124m 19.72%
Unlock
2028
$149m 19.93%
Unlock
2029
$170m 14.14%
Unlock
2030
$196m 15.26%
Unlock

EBITDA Margin

2024 14.25% 56.50%
2025
19.75% 38.61%
Unlock
2026
21.00% 6.33%
Unlock
2027
22.47% 7.00%
Unlock
2028
24.39% 8.54%
Unlock
2029
25.08% 2.83%
Unlock
2030
25.99% 3.63%
Unlock

9 CryoLife Analysts have issued a net profit forecast 2025. The average CryoLife net profit estimate is

$5.4m
Unlock
. This is
130.39% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$9.9m 155.25%
Unlock
, the lowest is
$-370k 97.93%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-13.3m 56.36%
2025
$5.4m 140.78%
Unlock
2026
$21.9m 303.31%
Unlock
2027
$28.8m 31.45%
Unlock
2028
$77.4m 168.24%
Unlock
2029
$97.6m 26.10%
Unlock
2030
$125m 28.08%
Unlock

Net Margin

2024 -3.43% 60.24%
2025
1.22% 135.53%
Unlock
2026
4.43% 263.11%
Unlock
2027
5.21% 17.61%
Unlock
2028
12.64% 142.61%
Unlock
2029
14.36% 13.61%
Unlock
2030
16.53% 15.11%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.32 0.12
57.33% 137.50%
P/E 367.84
EV/Sales 4.85

9 Analysts have issued a CryoLife forecast for earnings per share. The average CryoLife EPS is

$0.12
Unlock
. This is
130.77% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.21 153.85%
Unlock
, the lowest is
$-0.01 97.44%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.32 57.33%
2025
$0.12 137.50%
Unlock
2026
$0.47 291.67%
Unlock
2027
$0.61 29.79%
Unlock
2028
$1.64 168.85%
Unlock
2029
$2.07 26.22%
Unlock
2030
$2.65 28.02%
Unlock

P/E ratio

Current -108.85 8.97%
2025
367.84 437.94%
Unlock
2026
91.15 75.22%
Unlock
2027
69.33 23.94%
Unlock
2028
25.85 62.71%
Unlock
2029
20.50 20.70%
Unlock
2030
16.01 21.90%
Unlock

Based on analysts' sales estimates for 2025, the CryoLife stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.35 53.74%
2025
4.85 9.26%
Unlock
2026
4.38 9.74%
Unlock
2027
3.92 10.64%
Unlock
2028
3.54 9.49%
Unlock
2029
3.19 9.91%
Unlock
2030
2.87 10.09%
Unlock

P/S ratio

Current 4.95 77.21%
2025
4.48 9.34%
Unlock
2026
4.05 9.75%
Unlock
2027
3.62 10.64%
Unlock
2028
3.27 9.49%
Unlock
2029
2.95 9.91%
Unlock
2030
2.65 10.09%
Unlock

Current CryoLife Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Needham
Locked
Locked
Locked Aug 22 2025
Ladenburg Thalmann
Locked
Locked
Locked Aug 13 2025
Canaccord Genuity
Locked
Locked
Locked Aug 08 2025
Stifel
Locked
Locked
Locked Aug 08 2025
Needham
Locked
Locked
Locked Aug 08 2025
JMP Securities
Locked
Locked
Locked Aug 08 2025
Canaccord Genuity
Locked
Locked
Locked Jun 17 2025
Analyst Rating Date
Locked
Needham:
Locked
Locked
Aug 22 2025
Locked
Ladenburg Thalmann:
Locked
Locked
Aug 13 2025
Locked
Canaccord Genuity:
Locked
Locked
Aug 08 2025
Locked
Stifel:
Locked
Locked
Aug 08 2025
Locked
Needham:
Locked
Locked
Aug 08 2025
Locked
JMP Securities:
Locked
Locked
Aug 08 2025
Locked
Canaccord Genuity:
Locked
Locked
Jun 17 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today